Syncona Ltd ("Syncona" or the "Company"), a leading life science investor focused on creating, building and scaling global leaders in life science, today announces that its newly established portfolio company has entered into an agreement with Freeline Therapeutics Holdings plc ("Freeline") to acquire all of the .
Syncona Ltd on Thursday said net asset value decreased as it swung to a negative return in its latest half year, but that it is well-positioned for future growth thanks to its rich pipeline.
Syncona.
SwanBio Therapeutics, a gene therapy company developing AAV-based therapies for the treatment of devastating, inherited neurological conditions, today announced the addition of two industry.
SwanBio Therapeutics: SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathy finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.